Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 72

1.

Neuraminidase inhibitors: who, when, where?

Nguyen-Van-Tam JS, Venkatesan S, Muthuri SG, Myles PR.

Clin Microbiol Infect. 2015 Mar;21(3):222-225. doi: 10.1016/j.cmi.2014.11.020. Epub 2014 Nov 27. Review.

2.

Use of neuraminidase inhibitors for rapid containment of influenza: a systematic review and meta-analysis of individual and household transmission studies.

Okoli GN, Otete HE, Beck CR, Nguyen-Van-Tam JS.

PLoS One. 2014 Dec 9;9(12):e113633. doi: 10.1371/journal.pone.0113633. eCollection 2014.

3.

Amantadine and rimantadine for influenza A in children and the elderly.

Alves Galvão MG, Rocha Crispino Santos MA, Alves da Cunha AJ.

Cochrane Database Syst Rev. 2014 Nov 21;11:CD002745. doi: 10.1002/14651858.CD002745.pub4. Review.

PMID:
25415374
4.

[Multisystem failure: the story of antinfluenza drugs].

Jefferson T, Doshi P.

Recenti Prog Med. 2014 May;105(5):187-90. doi: 10.1701/1493.16451. Review. Italian.

PMID:
24873941
5.

Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.

Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Al Khuwaitir TS, Al Mamun A, Anovadiya AP, Azziz-Baumgartner E, Báez C, Bassetti M, Beovic B, Bertisch B, Bonmarin I, Booy R, Borja-Aburto VH, Burgmann H, Cao B, Carratala J, Denholm JT, Dominguez SR, Duarte PA, Dubnov-Raz G, Echavarria M, Fanella S, Gao Z, Gérardin P, Giannella M, Gubbels S, Herberg J, Iglesias AL, Hoger PH, Hu X, Islam QT, Jiménez MF, Kandeel A, Keijzers G, Khalili H, Knight M, Kudo K, Kusznierz G, Kuzman I, Kwan AM, Amine IL, Langenegger E, Lankarani KB, Leo YS, Linko R, Liu P, Madanat F, Mayo-Montero E, McGeer A, Memish Z, Metan G, Mickiene A, Mikić D, Mohn KG, Moradi A, Nymadawa P, Oliva ME, Ozkan M, Parekh D, Paul M, Polack FP, Rath BA, Rodríguez AH, Sarrouf EB, Seale AC, Sertogullarindan B, Siqueira MM, Skręt-Magierło J, Stephan F, Talarek E, Tang JW, To KK, Torres A, Törün SH, Tran D, Uyeki TM, Van Zwol A, Vaudry W, Vidmar T, Yokota RT, Zarogoulidis P; PRIDE Consortium Investigators, Nguyen-Van-Tam JS.

Lancet Respir Med. 2014 May;2(5):395-404. doi: 10.1016/S2213-2600(14)70041-4. Epub 2014 Mar 19. Review.

PMID:
24815805
6.

Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.

Heneghan CJ, Onakpoya I, Thompson M, Spencer EA, Jones M, Jefferson T.

BMJ. 2014 Apr 9;348:g2547. doi: 10.1136/bmj.g2547. Review.

7.

Multisystem failure: the story of anti-influenza drugs.

Jefferson T, Doshi P.

BMJ. 2014 Apr 10;348:g2263. doi: 10.1136/bmj.g2263. No abstract available.

PMID:
24721793
8.

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.

Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, Spencer EA, Onakpoya I, Mahtani KR, Nunan D, Howick J, Heneghan CJ.

Cochrane Database Syst Rev. 2014 Apr 10;4:CD008965. doi: 10.1002/14651858.CD008965.pub4. Review.

PMID:
24718923
9.

Critics attack chief medical officer's advice to use antivirals for flu.

Kmietowicz Z.

BMJ. 2014 Feb 12;348:g1496. doi: 10.1136/bmj.g1496. No abstract available.

PMID:
24526786
10.

Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis.

Jagannath VA, Asokan GV, Fedorowicz Z, Lee TW.

Cochrane Database Syst Rev. 2014 Feb 10;2:CD008139. doi: 10.1002/14651858.CD008139.pub3. Review.

PMID:
24515341
11.

Antivirals for influenza: a summary of a systematic review and meta-analysis of observational studies.

Santesso N, Hsu J, Mustafa R, Brozek J, Chen YL, Hopkins JP, Cheung A, Hovhannisyan G, Ivanova L, Flottorp SA, Saeterdal I, Wong AD, Tian J, Uyeki TM, Akl EA, Alonso-Coello P, Smaill F, Schünemann HJ.

Influenza Other Respir Viruses. 2013 Sep;7 Suppl 2:76-81. doi: 10.1111/irv.12085. Review.

PMID:
24034489
13.

Cochrane researchers continue to face challenges over access to data on flu drugs.

Kmietowicz Z.

BMJ. 2013 May 16;346:f3190. doi: 10.1136/bmj.f3190. No abstract available.

PMID:
23682054
14.

The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews.

Michiels B, Van Puyenbroeck K, Verhoeven V, Vermeire E, Coenen S.

PLoS One. 2013;8(4):e60348. doi: 10.1371/journal.pone.0060348. Epub 2013 Apr 2. Review.

15.

Management of influenza infection in solid-organ transplant recipients: consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI).

López-Medrano F, Cordero E, Gavaldá J, Cruzado JM, Marcos MÁ, Pérez-Romero P, Sabé N, Gómez-Bravo MÁ, Delgado JF, Cabral E, Carratalá J; Study Group of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases, Clinical Microbiology (SEIMC), Spanish Network for Research in Infectious Diseases (REIPI).

Enferm Infecc Microbiol Clin. 2013 Oct;31(8):526.e1-526.e20. doi: 10.1016/j.eimc.2013.01.013. Epub 2013 Mar 23. Review.

PMID:
23528341
16.

Executive summary. Management of influenza infection in solid-organ transplant recipients: consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI).

López-Medrano F, Cordero E, Gavaldá J, Cruzado JM, Marcos MÁ, Pérez-Romero P, Sabé N, Gómez-Bravo MÁ, Delgado JF, Cabral E, Carratalá J; Study Group of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases, Clinical Microbiology (SEIMC), Spanish Network for Research in Infectious Diseases (REIPI).

Enferm Infecc Microbiol Clin. 2013 Oct;31(8):528-34. doi: 10.1016/j.eimc.2013.01.014. Epub 2013 Mar 23. Review.

PMID:
23528340
17.

Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe.

Pozo F, Lina B, Andrade HR, Enouf V, Kossyvakis A, Broberg E, Daniels R, Lackenby A, Meijer A, Community Network of Reference Laboratories for Human Influenza in Europe.

J Clin Virol. 2013 May;57(1):5-12. doi: 10.1016/j.jcv.2013.01.009. Epub 2013 Jan 31.

PMID:
23375738
18.

Neuraminidase inhibitors for preventing and treating influenza in children (published trials only).

Wang K, Shun-Shin M, Gill P, Perera R, Harnden A.

Cochrane Database Syst Rev. 2012 Apr 18;4:CD002744. doi: 10.1002/14651858.CD002744.pub4. Review.

PMID:
22513907
19.

Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies.

Hsu J, Santesso N, Mustafa R, Brozek J, Chen YL, Hopkins JP, Cheung A, Hovhannisyan G, Ivanova L, Flottorp SA, Saeterdal I, Wong AD, Tian J, Uyeki TM, Akl EA, Alonso-Coello P, Smaill F, Schünemann HJ.

Ann Intern Med. 2012 Apr 3;156(7):512-24. doi: 10.7326/0003-4819-156-7-201204030-00411. Epub 2012 Feb 27. Review.

PMID:
22371849
20.

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.

Jefferson T, Jones MA, Doshi P, Del Mar CB, Heneghan CJ, Hama R, Thompson MJ.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD008965. doi: 10.1002/14651858.CD008965.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;4:CD008965.

PMID:
22258996
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk